You are here

Korea

Avanir, Strides are laying off US employees as Sanofi eyes early retirements in Korea: report

Avanir, Strides are laying off US employees as Sanofi eyes early retirements in Korea: report

Fierce Pharma

Avanir Pharmaceuticals

Flag link:

Korean firm LG Chem buying AVEO Oncology for $566M

Korean firm LG Chem buying AVEO Oncology for $566M

CP WIre

Flag link:

Korean firm LG Chem buying AVEO Oncology for $566M

Flag link:

Sanofi, eyeing impurity concerns, pulls hypertension meds in Korea and the UK. Could the next big 'sartan' recall be on the horizon?

Sanofi, eyeing impurity concerns, pulls hypertension meds in Korea and the UK. Could the next big 'sartan' recall be on the horizon?

Fierce Pharma

Flag link:

RIBOMIC enters license agreement with AJU Pharma for RBM-007 in age-related macular degeneration

RIBOMIC enters license agreement with AJU Pharma for RBM-007 in age-related macular degeneration

Pharmaceutical Business Review

age-related macular degeneration

Flag link:

Epilepsy's new company on the block wins FDA approval for made-in-Korea drug to treat focal seizures

Epilepsy's new company on the block wins FDA approval for made-in-Korea drug to treat focal seizures

Endpoints

partial onset seizures

SK Life Science

Flag link:

Once touted as Lyrica rival for diabetic nerve pain, Korean biotech's plasmid product implodes in PhIII

Once touted as Lyrica rival for diabetic nerve pain, Korean biotech's plasmid product implodes in PhIII

Endpoints

diabetic nerve pain

Flag link:

Takeda staffers accuse drugmaker of favoring Shire employees during merger: report

Takeda staffers accuse drugmaker of favoring Shire employees during merger: report

Fierce Pharma

Flag link:

Korean biotechs snatch U.S. stem cell manufacturing facility

Korean biotechs snatch U.S. stem cell manufacturing facility

Fierce Pharma

Flag link:

Novartis brings in new CEO to clean up scandal-hit Korean branch

Novartis brings in new CEO to clean up scandal-hit Korean branch

Fierce Pharma

Flag link:

Hanmi scraps lung cancer drug due to AstraZeneca rival, reports say

Hanmi scraps lung cancer drug due to AstraZeneca rival, reports say

Biopharma Dive

Flag link:

Boehringer Ingelheim denies rumors on acquisition of Korea’s CJ Healthcare ($896m)

Boehringer Ingelheim denies rumors on acquisition of Korea’s CJ Healthcare ($896m)

GoinPharma

Boehringer Ingelheim

Flag link:

FDA Warns Korean, Chinese Drugmakers

FDA Warns Korean, Chinese Drugmakers

RAPS.org

drug manufacturing

Flag link:

Deaths, accusations of insider trading and an early warning from Boehringer stir Hanmi controversy

Deaths, accusations of insider trading and an early warning from Boehringer stir Hanmi controversy

Endpoints

insider trading

Boehringer Ingelheim

Flag link:

2 patients dead, Boehringer scraps plans for high-speed development, kills $730M Hanmi deal

2 patients dead, Boehringer scraps plans for high-speed development, kills $730M Hanmi deal

Endpoints

Boehringer Ingelheim

drug development

Flag link:

Korean Healthtech Startup Closing In On Cure For Alzheimer's

Korean Healthtech Startup Closing In On Cure For Alzheimer's

Forbes

Alzheimer's disease

Flag link:

Sanofi buys into NeuroVive's cardio drug in Korea

Sanofi buys into NeuroVive's cardio drug in Korea

Fierce Biotech

Flag link:

Lilly inks a $690M deal to get its hands on an autoimmune drug

Lilly inks a $690M deal to get its hands on an autoimmune drug

Fierce Biotech

Hanmi Pharmaceutical

autoimmune disease

Flag link:

Inovio subsidiary sells animal health assets

Inovio subsidiary sells animal health assets

The Fly on the Wall

VGX Animal Health

Flag link:

Korean Partner Positions Pluristem To Be Cell Therapy Leader

Korean Partner Positions Pluristem To Be Cell Therapy Leader

Seeking Alpha

Advanced Cell Technology

Cha Bio&Diostech

Flag link:

Pages